| ²é¿´: 562 | »Ø¸´: 1 | |||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | |||
[½»Á÷]
Informative diagnostics for personalized medicine
|
|||
|
In addition to in vitro biomolecular diagnostics, advanced imaging technologies such as positron emission tomography (PET) and functional magnetic resonance imaging (fMRI) are having an increasingly important role in managing the treatment of disease, and chemical biologists can make substantial advances in the development of informative diagnostic imaging probes19. Disease-relevant small-molecule metabolic probes, active site binders, engineered proteins and new imaging tags, such as magnetic and optically active nanoparticles, will continue to help physicians monitor the spread of disease. The development of informative diagnostic methodologies is crucial if the biomedical research community is to realize the full potential of molecularly targeted therapeutics. Although early successes from the modern drug discovery process have offered hope for the personalized treatment of disease, a grand challenge now lies in the development of individualized diagnostic tools¡ªa challenge that must be met to translate this promise into the improved treatment of human disease. Chemical biologists are well positioned to lead this charge by expanding their efforts to include the development of informative clinical diagnostic methodologies, which should include collaborations with scientists with expertise in technologies that may just be appearing on the horizon. |
» ²ÂÄãϲ»¶
ÉúÎïѧ308·ÖÇóµ÷¼Á£¨Ò»Ö¾Ô¸»ª¶«Ê¦´ó£©
ÒѾÓÐ12È˻ظ´
µ÷¼ÁÇóÖú£¨ÉúÎïÓëÒ½Ò©£©
ÒѾÓÐ3È˻ظ´
Ò»Ö¾Ô¸¼ª´ó»¯Ñ§327Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
Ò»Ö¾Ô¸ÉúÎïÓëÒ½Ò©£¬296·Ö£¬Çóµ÷¼Á
ÒѾÓÐ13È˻ظ´
327Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
³õÊÔ301£¬´úÂë085701»·¾³¹¤³Ì£¬±¾Ë¶Ò»Ö£¬ËÄÁù¼¶Òѹý£¬ÓжþÇøÒ»×÷£¬¹²·¢±í5ƪÂÛÎÄ
ÒѾÓÐ8È˻ظ´
327¿¼Ñе÷¼ÁÍÆ¼ö
ÒѾÓÐ6È˻ظ´
328Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
304Çóµ÷¼Á
ÒѾÓÐ9È˻ظ´
»¯¹¤Çóµ÷¼Á£¡
ÒѾÓÐ16È˻ظ´
» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:
2007ÄêÒ»ÆðÍæË£µÄÀϳæ×ÓÃÇ£¬ÏëËÀÄãÃÇÀ²~~~³öÀ´Ã°¸öÅݰɡ¡
+1/180
ºÓ±±´óѧ·ÖÎö»¯Ñ§ÕÐÊÕ¶àÃûµ÷¼Á¿¼Éú
+3/116
Äþ²¨´óѧ2026Äê½ô¼±²¹ÕÐÖ²±£·½Ïò£¨À¥³æ»òÖ²²¡£©²©Ê¿Ñо¿Éú1-2Ãû
+1/92
Õã½Å©ÁÖ´óѧ»·¾³Óë×ÊԴѧԺ/̼ÖкÍѧԺ ÕÐÊÕµ÷¼ÁÉú£¬Ñ§Ë¶1Ãû¡¢×¨Ë¶2Ãû
+1/91
×ø±ê±±¾©£¬³ÏÕ÷Å®ÓÑ
+1/81
²ÄÁÏÓ뻯¹¤ ר˶µ÷¼Á
+1/40
ɽ¶«´óѧлÓñÉú¿ÎÌâ×é-³ÏƸ²©Ê¿ºó/¿ÆÑÐÖúÀí£¨³¤ÆÚÓÐЧ£©
+1/9
Ö£´ó¿ØÖÆÑ§¿Æ½ÌÊÚ²©µ¼Ñо¿ÉúÕÐÉú
+1/8
²³º£´óѧ´¢ÄܲÄÁÏ¿ÎÌâ×éÕÐÊÕµ÷¼ÁÑо¿Éú
+1/7
ÉÂÎ÷Àí¹¤´óѧ²ÄÁÏѧԺÐÂÄÜÔ´ÍŶÓÕе÷¼ÁÉú£¡£¡£¡
+1/5
Î人·ÄÖ¯´óѧȫ¹úÖØµãʵÑéÊÒÂÀÓÀ¸Ö½ÌÊÚ¿ÎÌâ×éÕÐÊÕ²ÄÁÏ¡¢»¯Ñ§¡¢ÉúÎïÏà¹Ø×¨ÒµË¶Ê¿Ñо¿Éú
+1/5
³¤½Ê¦·¶Ñ§Ôº ²ÄÁϹ¤³Ì ÕÐÊÕµ÷¼ÁѧÉú
+1/5
Î÷ÄϿƼ¼´óѧ¹ú¼ÒÖØµãʵÑéÊÒÀîÀÏʦ¿ÎÌâ×é½ÓÊÕ²ÄÁÏ¡¢»¯Ñ§ºÍ»¯¹¤ÀàÑо¿Éúµ÷¼Á
+1/5
Äϲý´óѧ¹¤³Ì½¨ÉèѧԺ2026ÄêÕÐÆ¸2Ãû¿ÆÑÐÖúÀí
+1/4
¡¾µ÷¼ÁÉϰ¶¡¿985ÁªºÏÅàÑø£¡1007/1055/08/07µÈ£¬²»ÏÞרҵ£¬ÏëÁªÅàµÄËÙÀ´£¡
+1/4
¹ãÖÝ˫һÁ÷´óѧ08´úÂëѧ˶½ÓÊܵ÷¼Á
+1/4
Ò»Ö¾Ô¸211µç×ÓÐÅÏ¢347Çóµ÷¼Á
+1/4
Î÷ÄϿƼ¼´óѧ¹ú¼ÒÖØµãʵÑéÊÒÀîÀÏʦ¿ÎÌâ×é½ÓÊÕ²ÄÁÏ¡¢»¯Ñ§ºÍ»¯¹¤ÀàÑо¿Éúµ÷¼Á
+1/4
Î人·ÄÖ¯´óѧȫ¹úÖØµãʵÑéÊÒÂÀÓÀ¸Ö½ÌÊÚ¿ÎÌâ×éÕÐÊÕ²ÄÁÏ¡¢»¯Ñ§¡¢ÉúÎïÏà¹Ø×¨ÒµË¶Ê¿Ñо¿Éú
+1/3
¹ã¶«Ê¡ÎåÒØ´óѧMOFs´ß»¯¹¦ÄܲÄÁÏ¿ÎÌâ×éÕÐÊÕ»¯Ñ§/²ÄÁϱ³¾°µ÷¼ÁÉú
+1/1
Õžü˧
ľ³æ (ÕýʽдÊÖ)
- ·ÒëEPI: 73
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ¹ó±ö: 0.005
- ½ð±Ò: 1037.1
- Ìû×Ó: 551
- ÔÚÏß: 79Сʱ
- ³æºÅ: 985303
ÓÚÌï9858(½ð±Ò+10, ·ÒëEPI+1): 2010-12-08 20:01:31
| ³ýÁËÌåÄÚÉúÎï·Ö×ÓÉϵÄÕï¶Ï£¬ÏȽøµÄ³ÉÏñ¼¼ÊõÈçÕýµç×ӶϲãɨÃèÒÇ(PET)ÒÔ¼°¹¦ÄÜÐԺ˴ʲÕñÔìÓ°(fMRI)ÔÚÖÎÁƼ²²¡ÉÏÈÕÒæÖØÒª£¬»¯Ñ§ÉúÎïѧ¼ÒÔÚÓ°ÏñÕï¶ÏѧµÄ̽Ë÷ÉÏҲȡµÃÁË´óÁ¿µÄ½ø²½¡£¼²²¡Ïà¹ØµÄС·Ö×Ó´úл̽Õ룬»îÐÔ²¿Î»Õ³ºÏ¼Á£¬¹¤³Ìµ°°×ÒÔ¼°ÐµijÉÏñ±ê¼ÇÎï±ÈÈç¾ßÓдÅÐԺ͹âѧ»îÐÔµÄÄÉÃ×Á£×Ó½«¼ÌÐø°ïÖúÄÚ¿ÆÒ½Éú¼à¿Ø¼²²¡µÄÂûÑÓ£¬Èç¹ûÉúÎïҽѧÑо¿ÉçȺҪʵÏÖ·Ö×ӰбêÖÎÁÆÉϵÄÈ«²¿Ç±ÄÜ£¬Õï¶Ï·½·¨Ñ§µÄ·¢Õ¹ÊÇ×î¹Ø¼üµÄ£¬¾¡¹ÜÏÖ´úÒ©Îï·¢ÏÖ¹ý³ÌµÄÔçÆÚµÄ³É¹¦ÒѾΪ¼²²¡µÄ¸öÐÔ»¯ÖÎÁÆÌṩϣÍû£¬¾Þ´óµÄÌôÕ½ÔÚÓÚ·¢Õ¹·¢Õ¹¸öÌ廯Õï¶Ï¹¤¾ß£¬Õâ¸öÌôÕ½¾ÍÊDZØÐëʵÏÖ°ÑÕâÏîÆÚÍûת±ä³ÉÖÎÁÆÈËÀ༲²¡µÄ¸Ä½ø·½·¨£¬»¯Ñ§ÉúÎïѧ¼ÒÇ¡ºÃ´¦ÓÚͨ¹ýËûÃǵÄŬÁ¦À´ÖªµÀÕâÏîʹÃüÒÔÍÆ¶¯ÁÙ´²Õï¶Ï·½·¨Ñ§µÄ·¢Õ¹µÄλÖÃÉÏ¡£Õâ¾Í°üÀ¨Óë¼¼ÊõÉÏÓÐרÃÅ֪ʶ¿ÆÑ§¼ÒµÄºÏ×÷£¬¸Ã¼¼Êõ¿ÉÄÜÒѾ³õ¶¶ËÄß¡£ |
2Â¥2010-12-08 17:05:31














»Ø¸´´ËÂ¥